PHARMING GRP SP. ADRS
PHARMING GRP SP. ADRS
Depository Receipt · US71716E1055 · PHAR · A2QLQY (XFRA)
Overview
10,09 EUR
-3,58 % -0,37 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 18:45

Current Prices from PHARMING GRP SP. ADRS

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
PHAR
USD
10.06.2025 18:45
11,52 USD
11,95 USD
-3,58 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -5,14 % 12,84 % 38,18 % 21,05 % 32,17 % -31,82 %

Company Profile for PHARMING GRP SP. ADRS Depository Receipt

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Company Data

Name PHARMING GRP SP. ADRS
Company Pharming Group N.V.
Symbol PHAR
Website https://www.pharming.com
Primary Exchange XFRA Frankfurt
WKN A2QLQY
ISIN US71716E1055
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. Fabrice Chouraqui Ph.D., Pharm.D.
Market Capitalization 559 Mio
Country Netherlands
Currency EUR
Employees 0,4 T
Address Darwinweg 24, 2333 CR Leiden
IPO Date 2020-12-23

Ticker Symbols

Name Symbol
Frankfurt PHG.F
NASDAQ PHAR

More Shares

Investors who PHARMING GRP SP. ADRS hold also have the following shares in their portfolio:
EUROPEAN BANK FOR RECONSTRUCTION & DEVELOPMENT ZERO CPN NTS 15/04/38
EUROPEAN BANK FOR RECONSTRUCTION & DEVELOPMENT ZERO CPN NTS 15/04/38 Bond
PNC FINL SVC 22/UND. FLR
PNC FINL SVC 22/UND. FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025